🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Recognizing Top Oncologists, Top Women Oncologists, and Rising Stars from ASCO 2025 at Times Square! Dr Amol Akhade | Paolo Tarantino | Aakash Desai, MD, MPH, FASCO | Stephen V Liu, MD | Hidehito HORINOUCHI | Toni Choueiri, MD | Yakup Ergün | Neeraj Agarwal, MD, FASCO | Andrea Necchi | Sharlene Gill, MD, MPH, MBA, FASCO | Aya Mohamed | MSc, MD 🎗 |

Happy to join Elizabeth Plimack MD and UroToday.com in this discussion on our #SURE02 trial and on newer bladder-sparing approaches Chiara Mercinelli Valentina Tateo Antonio Cigliola Brigida Maiorano ASCO Ospedale San Raffaele Università Vita-Salute San Raffaele Elai Davicioni Joep J. de Jong Veracyte, Inc. Foundation Medicine Fondazione AIRC per la ricerca sul cancro associazionepalinuro

SURE-02: Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab, Response-Adapted Bladder Sparing, and Adjuvant Pembrolizumab for Patients With MIBC guoncologynow.com/post/sure-02-n…

Perioperative Sacituzumab Govitecan Plus Pembrolizumab Is Safe, Active in MIBC onclive.com/view/periopera… via @onclive

Thank you Andrea Necchi for an outstanding VP with us at Univ of Toronto Urology. Tour-de-force overview of the current landscape of NMIBC and MIBC and the importance of multi-disciplinary management in bladder cancer!

Video in @UroToday: Zach Klaassen interviews Andrea Necchi about MRI radiomics analysis from the PURE-01 study: 3 cycles of neoadjuvant pembrolizumab in MIBC with pre- and post-treatment MRI imaging in 112 patients. Click to watch: urotoday.com/categories-med…

STARTING NOW‼️#GUARDSymposium2025 Join us ONLINE for the GUARD Symposium🇪🇸 featuring interactive workshops where experts collaboratively discuss real-world genitourinary cancer cases. REGISTER👉 events.tacticsmd.net/guard-internat… ⭐️FREE VIRTUAL Admission for LMIC's & LATAM Colleagues⭐️

Impact of molecular androgen and estrogen response scores on outcomes following neoadjuvant pembrolizumab in muscle-invasive #BladderCancer aacrjournals.org/clincancerres/… This post-hoc analysis of the PURE-01 trial investigated the influence of androgen and estrogen genomic signatures

Radiation vs systemic therapy for isolated pelvic recurrence after cystectomy. Ashish M. Kamat, MD, MBBS moderates a debate between Andrea Necchi Ospedale San Raffaele & Comron Hassanzadeh, MD, MPH MD Anderson Cancer Center. Comron Hassanzadeh backs pelvic radiation for isolated recurrence, while Andrea Necchi